ES2196528T3 - Derivados de gemcitabina. - Google Patents
Derivados de gemcitabina.Info
- Publication number
- ES2196528T3 ES2196528T3 ES98901592T ES98901592T ES2196528T3 ES 2196528 T3 ES2196528 T3 ES 2196528T3 ES 98901592 T ES98901592 T ES 98901592T ES 98901592 T ES98901592 T ES 98901592T ES 2196528 T3 ES2196528 T3 ES 2196528T3
- Authority
- ES
- Spain
- Prior art keywords
- gemcitabine
- eicosenoyl
- amides
- sub
- gemcitabine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical class O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 title abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 125000004016 elaidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])/C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- -1 trans-eicosenoyl Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención se refiere a ésteres o amidas de gemcitabina, en los que el grupo 3''-y/o 5''-OH y/o el grupo N{sup,4}-amino se deriva mediante un grupo acilo C{sub,18} y/o C{sub,20} saturado o monosaturado, preferentemente un grupo acilo elegido entre oleoilo, elaidoilo, cis-eicosenoilo y trans-eicosenoilo. Los ésteres y amidas de gemcitabina son útiles como agentes anticancerosos y antivirales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9701427A GB2321454A (en) | 1997-01-24 | 1997-01-24 | Gemcitabine esters and amides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2196528T3 true ES2196528T3 (es) | 2003-12-16 |
Family
ID=10806509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98901592T Expired - Lifetime ES2196528T3 (es) | 1997-01-24 | 1998-01-23 | Derivados de gemcitabina. |
Country Status (7)
| Country | Link |
|---|---|
| CZ (1) | CZ293245B6 (es) |
| ES (1) | ES2196528T3 (es) |
| GB (1) | GB2321454A (es) |
| IL (1) | IL130971A0 (es) |
| RU (1) | RU2194711C2 (es) |
| TW (1) | TW458981B (es) |
| ZA (1) | ZA98576B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2270706C2 (ru) * | 2004-04-05 | 2006-02-27 | Государственное учреждение научно-исследовательский институт онкологии Томского научного центра Сибирского отделения Российской академии медицинских наук(ГУ НИИ онкологии ТНЦ СО РАМН) | Способ комбинированного лечения больных немелкоклеточным раком легкого iii стадии |
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| CA2589850C (en) * | 2004-12-17 | 2012-05-01 | Eli Lilly And Company | Amide prodrug of gemcitabine, compositions and use thereof |
| US8962614B2 (en) * | 2008-04-17 | 2015-02-24 | The Johns Hopkins University | ON01910.Na enhances chemotherapeutic agent activity in drug-resistant tumors |
| CA2891124A1 (en) | 2012-11-13 | 2014-05-22 | BoYen Therapeutics, Inc. | Gemcitabine prodrugs and uses thereof |
| CN110713502A (zh) * | 2019-11-29 | 2020-01-21 | 南京科技职业学院 | 一种吉西他滨杂质的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0329348B1 (en) * | 1988-02-16 | 1995-07-12 | Eli Lilly And Company | 2',3'-Dideoxy-2',2'-difluoronucleosides |
| YU43193A (sh) * | 1992-06-22 | 1997-01-08 | Eli Lilly And Company | 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi |
-
1997
- 1997-01-24 GB GB9701427A patent/GB2321454A/en not_active Withdrawn
-
1998
- 1998-01-23 RU RU99118222/04A patent/RU2194711C2/ru not_active IP Right Cessation
- 1998-01-23 IL IL13097198A patent/IL130971A0/xx not_active IP Right Cessation
- 1998-01-23 ES ES98901592T patent/ES2196528T3/es not_active Expired - Lifetime
- 1998-01-23 ZA ZA98576A patent/ZA98576B/xx unknown
- 1998-01-23 CZ CZ19992479A patent/CZ293245B6/cs not_active IP Right Cessation
- 1998-03-13 TW TW087103708A patent/TW458981B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2321454A (en) | 1998-07-29 |
| GB9701427D0 (en) | 1997-03-12 |
| CZ247999A3 (cs) | 1999-12-15 |
| IL130971A0 (en) | 2001-01-28 |
| ZA98576B (en) | 1998-07-23 |
| TW458981B (en) | 2001-10-11 |
| CZ293245B6 (cs) | 2004-03-17 |
| RU2194711C2 (ru) | 2002-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69812934D1 (de) | Gemcitabin-derivate | |
| ES2142242B1 (es) | Combinacion de estabilizadores. | |
| ES2113867T3 (es) | Imino-derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| GT199900067A (es) | Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica. | |
| MX9302448A (es) | Derivados iminicos ciclicos, procedimientos para su preparacion y medicamentos que contienen estos compuestos. | |
| GT199900185A (es) | Novedosa pirimidin-4-enamina como fungicida. | |
| CO4370056A1 (es) | Producto poroso globulizado de baja densidad y proceso para su elaboracion | |
| ES2196528T3 (es) | Derivados de gemcitabina. | |
| ES2151168T3 (es) | N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
| ES2092981T3 (es) | Derivados de aristeromicina/adenosina. | |
| PA8461601A1 (es) | Isoquinolinas | |
| ES2143181T3 (es) | Derivados biciclicos de isotiourea utiles en terapia. | |
| ES2062249T3 (es) | Reloj sincronizado. | |
| MX9303709A (es) | Nucleosidos de purina substituidos e intermediarios de los mismos, que tienen actividad anti-viral y anti-cancerigena y composicion farmaceutica que los contiene. | |
| ES2116601T3 (es) | Derivados de isoquinolina como agentes terapeuticos. | |
| ES2156293T3 (es) | Metodo para producir vasodilatacion con derivados de (1,5-inter)arilprostaglandina. | |
| PE28297A1 (es) | Empleo dermatologico de derivados de vitamina d | |
| ES2117664T3 (es) | Carboximetilmanoglucanos y derivados de los mismos. | |
| ES2099865T3 (es) | Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares. | |
| ES2056431T3 (es) | Procedimiento para la produccion de r(+)-aminocarnitina y s(-)-aminocarnitina. | |
| ES2179070T3 (es) | Derivados del taxano c9 y composiciones farmaceuticas que las contienen. | |
| ES2034504T3 (es) | Chasis de bogie. | |
| ES2103131T3 (es) | Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias. | |
| MX9204736A (es) | Uretanos ciclicos utiles como agentes antiarritmicos y antifibrilatorios. | |
| CO4440530A1 (es) | Emulsionador emulsion de agua en aceite |